Assessment of Minimal Residual Disease in Standard-Risk AML - Ivey, Adam; Hills, Robert K; Simpson, Michael A; Jovanovic, Jelena V; Gilkes, Amanda; Grech, Angela; Patel, Yashma; Bhudia, Neesa; Farah, Hassan; Mason, Joanne; Wall, Kerry; Akiki, Susanna; et al. (The New England journal of medicine, 2016)
Keywords: Acute myeloid leukemia; Base Sequence; Chemotherapy; Clinical trials; DNA, Neoplasm - analysis; Exome; Gene Expression Profiling; Genes; Genetic markers; Health risk assessment; Humans; Leukemia; Leukemia, Myeloid, Acute - genetics; Medical prognosis; Minimal residual disease; Molecular Sequence Data; Multivariate analysis; Mutation; Myeloid leukemia; Neoplasm, Residual - genetics; Nuclear Proteins - genetics; Nuclear Proteins - metabolism; Nucleophosmin; Patients; Polymerase chain reaction; Prognosis; Quantitation; Recurrence; Remission; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; Transcriptome